Gosebruch Henry is a director or executive at Lakefront Biotherapeutics and is subject to EU Market Abuse Regulation disclosure requirements due to their senior position. Their role provides privileged access to material non-public information, requiring mandatory disclosure of securities transactions in company shares.
1J rendement
+0.1%
Transactiegeschiedenis
2
Transactiegeschiedenis
2 signaaltransacties· 3 ruw gemeld1 transactie uitgesloten van signaalranglijsten. Een of meer meldingen voor deze persoon lijken betrekking te hebben op accountconsolidatie, accountoverdrachten of portefeuilleherstructurering. Hieronder weergegeven voor transparantie, maar uitgesloten van prestatieberekeningen en signaalfeeds.
Zijde
🇧🇪
Reported purchaseGosebruch HenryEU MAR
LKFTOther
LAKEFRONT BIOTHERAPEUTICS
BE0003818359
~€159K
@ €23.45
🇧🇪
Neutral — compensation/vestingGosebruch HenryEU MAR
LKFTOther
LAKEFRONT BIOTHERAPEUTICS
BE0003818359
Undisclosed
Not an insider buy/sell signal. This transaction is part of a compensation or vesting arrangement. Shares received through remuneration and subsequently sold for tax or liquidity purposes are classified as neutral and excluded from signal analysis.